Regulation and Signaling of Red Blood Cell (RBC) Endothelial Nitric Oxide Synthase (eNOS) in Patients With Stable and Unstable Coronary Artery Disease
Regulation and Signaling of RBC-eNOS in Patients With Stable and Unstable Coronary Artery Disease
Sponsor: Heinrich-Heine University, Duesseldorf
A observational or N/A phase clinical study on Coronary Artery Disease and Endothelial NO-synthase, this trial is completed. The trial is conducted by Heinrich-Heine University, Duesseldorf and has accumulated 15 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Mar 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 10 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Mar 2019 — Aug 2020 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heinrich-Heine University, Duesseldorf
For direct contact, visit the study record on ClinicalTrials.gov .